Related Experiment Videos
Methodology in prostaglandin and thromboxane assay.
1Department of Physiological Chemistry, Karolinska Institutet, Stockholm, Sweden.
Progress in Lipid Research
|January 1, 1986
Summary
Measuring prostaglandin and thromboxane metabolites requires careful selection of assay targets. The study highlights 11-dehydro-thromboxane B2 as a more reliable indicator than thromboxane B2 due to artifactual formation issues.
Area of Science:
- Biochemistry
- Analytical Chemistry
- Pharmacology
Background:
- Prostaglandin and thromboxane assays face challenges due to metabolic instability and artifactual formation.
- Accurate measurement requires selecting stable metabolites that represent the pathway and are not sample-processing artifacts.
Purpose of the Study:
- To identify optimal target compounds for reliable prostaglandin and thromboxane assays.
- To evaluate thromboxane B2 (TxB2) and its metabolite 11-dehydro-TxB2 as assay targets.
Main Methods:
- Review of prostaglandin and thromboxane metabolism.
- Kinetic studies using a radioimmunoassay for TxB2 metabolism in humans.
Main Results:
- Prostaglandins E and F, and sometimes D, can be reliably assayed by monitoring 15-ketodihydro metabolites or beta-oxidized products.
- Thromboxane B2 (TxB2) is unsuitable for monitoring due to artifactual formation during sample collection.
- 11-dehydro-TxB2 is identified as a more reliable indicator of thromboxane pathway activity, despite pH-dependent equilibrium challenges.
Conclusions:
- Metabolic considerations are crucial for overcoming difficulties in prostaglandin and thromboxane assays.
- 11-dehydro-TxB2 provides a more accurate assessment of thromboxane metabolism compared to TxB2.
- The selection of stable, representative metabolites is key to accurate biochemical pathway analysis.